EPITHELIOID PLEURAL MESOTHELIOMA

Clinical trials for EPITHELIOID PLEURAL MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new EPITHELIOID PLEURAL MESOTHELIOMA trials appear

Sign up with your email to follow new studies for EPITHELIOID PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New combo therapy shows promise for rare lung cancer

Disease control Ongoing

This study tests whether giving a combination of the immunotherapy drug pembrolizumab and chemotherapy before surgery can help people with a rare cancer called pleural mesothelioma. The trial involves 41 adults with early-stage disease that can be surgically removed. The main goa…

Matched conditions: EPITHELIOID PLEURAL MESOTHELIOMA

Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

EPITHELIOID PLEURAL MESOTHELIOMA

Get alerted when new EPITHELIOID PLEURAL MESOTHELIOMA trials appear

New combo therapy shows promise for rare lung cancer